{
    "medicine_id": "a0a58d5417333cdc7d7051dba8df035e2763d54b",
    "platform_id": "DB00904",
    "metadata": {
        "name": "Accel ondansetron 8 mg Solution",
        "composition": "8 mg Ondansetron",
        "clinical_particulars": {
            "therapeutic_indications": "In the adult patient population i orally administered ondansetron tablets and orally disintegrating tablets ODT are indicated for the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy including high dose ie greater than or equal to 50 mg m2 cisplatin therapy and radiotherapy and the prevention and treatment of postoperative nausea and vomiting ii intravenously administered ondansetron injection formulations are indicated for the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy including high dose ie greater than or equal to 50 mg m2 cisplatin therapy and the prevention and treatment of postoperative nausea and vomiting In the pediatric 4 18 years of age patient population i ondansetron was effective and well tolerated when given to children 4 12 years of age for the treatment of post chemotherapy induced nausea and vomiting ii ondansetron tablets ondansetron ODT ondansetron injection are not indicated for the treatment of children 3 years of age or younger iii ondansetron tablets ondansetron ODT ondansetron injection are not indicated for use in any age group of the pediatric population for the treatment of post radiotherapy induced nausea and vomiting and iV ondansetron tablets ondansetron ODT ondansetron injection are not indicated for use in any age group of the pediatric population for the treatment of postoperative nausea and vomiting In the geriatric 65 years of age patient population i efficacy and tolerance of ondansetron were similar to that observed in younger adults for the treatment of post chemotherapy and radiotherapy induced nausea and vomiting and ii clinical experience in the use of ondansetron in the prevention and treatment of postoperative nausea and vomiting is limited and is not indicated for use in the geriatric patient population",
            "contraindications": {
                "disease": "At present there is little information concerning overdosage with ondansetron F3178 F3181 F3184 Nevertheless there have been certain cases of somewhat idiosyncratic adverse effects associated with particular dosages of ondansetron used F3178 F3181 F3184 Sudden blindness amaurosis of 2 to 3 minutes duration plus severe constipation occurred in one patient that was administered 72 mg of ondansetron intravenously as a single dose F3178 F3181 F3184 Hypotension and faintness occurred in another patient that took 48 mg of oral ondansetron F3178 F3181 F3184 Following infusion of 32 mg over only a 4 minute period a vasovagal episode with transient second degree heart block was observed F3178 F3181 F3184 Neuromuscular abnormalities autonomic instability somnolence and a brief generalized tonic clonic seizure which resolved after a dose of benzodiazepine were observed in a 12 month old infant who ingested seven or eight 8 mg ondansetron tablets approximately forty times the recommended 0 1 0 15 mg kg dose for a pediatric patient F3178 F3181 F3184 In all instances however the events resolved completely F3178 F3181 F3184 The safety of ondansetron for use in human pregnancy has not been established F3181 F3184 Ondansetron is not teratogenic in animals F3181 F3184 However as animal studies are not always predictive of human response the use of ondansetron in pregnancy is not recommended F3181 F3184 Ondansetron is excreted in the milk of lactating rats F3181 F3184 It is not known if it is excreted in human milk however nursing is not recommended during treatment with ondansetron F3181 F3184 Insufficient information is available to provide dosage recommendations for children 3 years of age or younger F3181 F3184",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Ondansetron is a highly specific and selective serotonin 5 HT sub 3 sub receptor antagonist not shown to have activity at other known serotonin receptors and with low affinity for dopamine receptors FDA Label A1160 A1161 The serotonin 5 HT sub 3 sub receptors are located on the nerve terminals of the vagus in the periphery and centrally in the chemoreceptor trigger zone of the area postrema FDA Label A1160 A1161 The temporal relationship between the emetogenic action of emetogenic drugs and the release of serotonin as well as the efficacy of antiemetic agents suggest that chemotherapeutic agents release serotonin from the enterochromaffin cells of the small intestine by causing degenerative changes in the GI tract FDA Label A1160 A1161 The serotonin then stimulates the vagal and splanchnic nerve receptors that project to the medullary vomiting center as well as the 5 HT sub 3 sub receptors in the area postrema thus initiating the vomiting reflex causing nausea and vomiting FDA Label A1160 A1161 Moreover the effect of ondansetron on the QTc interval was evaluated in a double blind randomized placebo and positive moxifloxacin controlled crossover study in 58 healthy adult men and women F3181 F3184 Ondansetron was tested at single doses of 8 mg and 32 mg infused intravenously over 15 minutes F3181 F3184 At the highest tested dose of 32 mg prolongation of the Fridericia corrected QTc interval QT RR0 33 QTcF was observed from 15 min to 4 h after the start of the 15 min infusion with a maximum mean upper limit of 90 CI difference in QTcF from placebo after baseline correction of 19 6 21 5 msec at 20 min F3181 F3184 At the lower tested dose of 8 mg QTc prolongation was observed from 15 min to 1 h after the start of the 15 minute infusion with a maximum mean upper limit of 90 CI difference in QTcF from placebo after baseline correction of 5 8 7 8 msec at 15 min F3181 F3184 The magnitude of QTc prolongation with ondansetron is expected to be greater if the infusion rate is faster than 15 minutes F3181 F3184 The 32 mg intravenous dose of ondansetron must not be administered F3181 F3184 No treatment related effects on the QRS duration or the PR interval were observed at either the 8 or 32 mg dose F3181 F3184 An ECG assessment study has not been performed for orally administered ondansetron F3181 F3184 On the basis of pharmacokinetic pharmacodynamic modelling an 8 mg oral dose of ondansetron is predicted to cause a mean QTcF increase of 0 7 ms 90 CI 2 1 3 3 at steady state assuming a mean maximal plasma concentration of 24 7 ng mL 95 CI 21 1 29 0 F3181 F3184 The magnitude of QTc prolongation at the recommended 5 mg m2 dose in pediatrics has not been studied but pharmacokinetic pharmacodynamic modeling predicts a mean increase of 6 6 ms 90 CI 2 8 10 7 at maximal plasma concentrations F3181 F3184 In healthy subjects single intravenous doses of 0 15 mg kg of ondansetron had no effect on esophageal motility gastric motility lower esophageal sphincter pressure or small intestinal transit time F3178 Multiday administration of ondansetron has been shown to slow colonic transit in healthy subjects F3178 Ondansetron has no effect on plasma prolactin concentrations F3178",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB09083",
                        "description": "Ivabradine may increase the QTc prolonging activities of Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Buprenorphine"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "Doxylamine may increase the central nervous system depressant CNS depressant activities of Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00470",
                        "description": "Dronabinol may increase the central nervous system depressant CNS depressant activities of Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "Droperidol may increase the central nervous system depressant CNS depressant activities of Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00956",
                        "description": "Hydrocodone may increase the central nervous system depressant CNS depressant activities of Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The therapeutic efficacy of Ondansetron can be increased when used in combination with Magnesium sulfate"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB00765",
                        "description": "Ondansetron may increase the sedative activities of Metyrosine"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "Minocycline may increase the central nervous system depressant CNS depressant activities of Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "Nabilone may increase the central nervous system depressant CNS depressant activities of Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Orphenadrine"
                    },
                    {
                        "drugbank-id": "DB09117",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Paraldehyde"
                    },
                    {
                        "drugbank-id": "DB08883",
                        "description": "Perampanel may increase the central nervous system depressant CNS depressant activities of Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "Ondansetron may increase the sedative activities of Pramipexole"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "Ondansetron may increase the sedative activities of Rotigotine"
                    },
                    {
                        "drugbank-id": "DB06201",
                        "description": "The risk or severity of adverse effects can be increased when Rufinamide is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09072",
                        "description": "Sodium oxybate may increase the central nervous system depressant CNS depressant activities of Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Suvorexant"
                    },
                    {
                        "drugbank-id": "DB06204",
                        "description": "Tapentadol may increase the central nervous system depressant CNS depressant activities of Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Thalidomide"
                    },
                    {
                        "drugbank-id": "DB00425",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Zolpidem"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "The therapeutic efficacy of Ondansetron can be increased when used in combination with Yohimbine"
                    },
                    {
                        "drugbank-id": "DB00315",
                        "description": "The metabolism of Zolmitriptan can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of adverse effects can be increased when Methadone is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Apomorphine"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Phenindione"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Coumarin"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Tioclomarol"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with 4 hydroxycoumarin"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Ethyl biscoumacetate"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Clorindione"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Diphenadione"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "Ondansetron may increase the serotonergic activities of Mirtazapine"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Ethanol"
                    },
                    {
                        "drugbank-id": "DB00972",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Azelastine"
                    },
                    {
                        "drugbank-id": "DB00484",
                        "description": "Brimonidine may increase the central nervous system depressant CNS depressant activities of Ondansetron"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Zimelidine"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Dapoxetine"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Sertraline"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Sibutramine"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Nefazodone"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Milnacipran"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Desvenlafaxine"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Levomilnacipran"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Indalpine"
                    },
                    {
                        "drugbank-id": "DB13233",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Alaproclate"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The risk or severity of adverse effects can be increased when Seproxetine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "Ondansetron may increase the serotonergic activities of Methylene blue"
                    },
                    {
                        "drugbank-id": "DB00209",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Trospium"
                    },
                    {
                        "drugbank-id": "DB00219",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Oxyphenonium"
                    },
                    {
                        "drugbank-id": "DB00332",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Ipratropium"
                    },
                    {
                        "drugbank-id": "DB00340",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Metixene"
                    },
                    {
                        "drugbank-id": "DB00376",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Trihexyphenidyl"
                    },
                    {
                        "drugbank-id": "DB00383",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Oxyphencyclimine"
                    },
                    {
                        "drugbank-id": "DB00387",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Procyclidine"
                    },
                    {
                        "drugbank-id": "DB00392",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Profenamine"
                    },
                    {
                        "drugbank-id": "DB00462",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Methscopolamine bromide"
                    },
                    {
                        "drugbank-id": "DB00505",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Tridihexethyl"
                    },
                    {
                        "drugbank-id": "DB00517",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Anisotropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00670",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Pirenzepine"
                    },
                    {
                        "drugbank-id": "DB00725",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Homatropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Propantheline"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Dicyclomine"
                    },
                    {
                        "drugbank-id": "DB00940",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Methantheline"
                    },
                    {
                        "drugbank-id": "DB00942",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Cycrimine"
                    },
                    {
                        "drugbank-id": "DB00986",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Glycopyrronium"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Flavoxate"
                    },
                    {
                        "drugbank-id": "DB01231",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Diphenidol"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Tiotropium"
                    },
                    {
                        "drugbank-id": "DB01625",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Isopropamide"
                    },
                    {
                        "drugbank-id": "DB04843",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Mepenzolate"
                    },
                    {
                        "drugbank-id": "DB06787",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Hexocyclium"
                    },
                    {
                        "drugbank-id": "DB08801",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Dimetindene"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Aclidinium"
                    },
                    {
                        "drugbank-id": "DB08997",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Dexetimide"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Imidafenacin"
                    },
                    {
                        "drugbank-id": "DB09300",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Butylscopolamine"
                    },
                    {
                        "drugbank-id": "DB11235",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Thonzylamine"
                    },
                    {
                        "drugbank-id": "DB11315",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Methscopolamine"
                    },
                    {
                        "drugbank-id": "DB12086",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Oxitropium"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Propiverine"
                    },
                    {
                        "drugbank-id": "DB12526",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Batefenterol"
                    },
                    {
                        "drugbank-id": "DB12554",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Mebeverine"
                    },
                    {
                        "drugbank-id": "DB13252",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Tropatepine"
                    },
                    {
                        "drugbank-id": "DB13254",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Prifinium"
                    },
                    {
                        "drugbank-id": "DB13351",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Piperidolate"
                    },
                    {
                        "drugbank-id": "DB13369",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Benzilone"
                    },
                    {
                        "drugbank-id": "DB13380",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Difemerine"
                    },
                    {
                        "drugbank-id": "DB13413",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Phenglutarimide"
                    },
                    {
                        "drugbank-id": "DB13448",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Mazaticol"
                    },
                    {
                        "drugbank-id": "DB13468",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Etybenzatropine"
                    },
                    {
                        "drugbank-id": "DB13507",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Poldine"
                    },
                    {
                        "drugbank-id": "DB13542",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Bevonium"
                    },
                    {
                        "drugbank-id": "DB13581",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Rociverine"
                    },
                    {
                        "drugbank-id": "DB13619",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Bornaprine"
                    },
                    {
                        "drugbank-id": "DB13636",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Etanautine"
                    },
                    {
                        "drugbank-id": "DB13666",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Tiemonium iodide"
                    },
                    {
                        "drugbank-id": "DB13678",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Dihexyverine"
                    },
                    {
                        "drugbank-id": "DB13695",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Penthienate"
                    },
                    {
                        "drugbank-id": "DB13720",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Diphemanil"
                    },
                    {
                        "drugbank-id": "DB13738",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Camylofin"
                    },
                    {
                        "drugbank-id": "DB13759",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Fenpiverinium"
                    },
                    {
                        "drugbank-id": "DB13769",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Emetonium iodide"
                    },
                    {
                        "drugbank-id": "DB13844",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Pipenzolate"
                    },
                    {
                        "drugbank-id": "DB13850",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Timepidium"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Doxepin"
                    },
                    {
                        "drugbank-id": "DB00747",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Scopolamine"
                    },
                    {
                        "drugbank-id": "DB00767",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Benzquinamide"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Fesoterodine"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Umeclidinium"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Revefenacin"
                    },
                    {
                        "drugbank-id": "DB09007",
                        "description": "Ondansetron may increase the central nervous system depressant CNS depressant activities of Chlorphenoxamine"
                    },
                    {
                        "drugbank-id": "DB01198",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Zopiclone"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Clemastine"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Ibutilide"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Trovafloxacin"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Cocaine"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Domperidone"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Sparfloxacin"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Bepridil"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Tetrabenazine"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Artemether"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Deutetrabenazine"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Macimorelin"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Terodiline"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of QTc prolongation can be increased when Citalopram is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of QTc prolongation can be increased when Thioridazine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of QTc prolongation can be increased when Flupentixol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Eliglustat"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The risk or severity of QTc prolongation can be increased when Cisapride is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Dofetilide"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "The risk or severity of QTc prolongation can be increased when Betaxolol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Perflutren is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The risk or severity of QTc prolongation can be increased when Cinnarizine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "The risk or severity of QTc prolongation can be increased when Propranolol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "The risk or severity of QTc prolongation can be increased when Atropine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "The risk or severity of QTc prolongation can be increased when Adenosine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of QTc prolongation can be increased when Pentamidine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of QTc prolongation can be increased when Carbinoxamine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The risk or severity of QTc prolongation can be increased when Roxithromycin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Cinoxacin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Lomefloxacin"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Dimenhydrinate"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Papaverine"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Nifedipine"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Gemifloxacin"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Ofloxacin"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Acebutolol"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Probucol"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Terlipressin"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Prenylamine"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Azimilide"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Pracinostat"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Technetium Tc 99m ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Garenoxacin"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Tedisamil"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Tucidinostat"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Telavancin"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Nemonoxacin"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Antazoline"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Bedaquiline"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Fendiline"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Eperisone"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Benidipine"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11640",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Mocetinostat"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Entinostat"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with CUDC 101"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Simendan"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Ricolinostat"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Mizolastine"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Abexinostat"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Oxatomide"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Sitafloxacin"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Otilonium"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Nizofenone"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Bunaftine"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Lorcainide"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Dexchlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The risk or severity of QTc prolongation can be increased when Loperamide is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Levofloxacin"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Dexverapamil"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Ivosidenib"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Emedastine"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Encorafenib"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of QTc prolongation can be increased when Octreotide is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "The risk or severity of QTc prolongation can be increased when Esmolol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of QTc prolongation can be increased when Buclizine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "The risk or severity of QTc prolongation can be increased when Timolol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The risk or severity of QTc prolongation can be increased when Galantamine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of QTc prolongation can be increased when Moricizine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Moexipril is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of QTc prolongation can be increased when Azatadine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The risk or severity of QTc prolongation can be increased when Indapamide is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The risk or severity of QTc prolongation can be increased when Famotidine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of QTc prolongation can be increased when Felbamate is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The risk or severity of QTc prolongation can be increased when Formoterol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of QTc prolongation can be increased when Desflurane is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "The risk or severity of QTc prolongation can be increased when Encainide is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01426",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01620",
                        "description": "The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "The risk or severity of QTc prolongation can be increased when Cariporide is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Degarelix is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Buserelin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Histrelin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of QTc prolongation can be increased when Eribulin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "The risk or severity of QTc prolongation can be increased when Indenolol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The risk or severity of QTc prolongation can be increased when Flumequine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The risk or severity of QTc prolongation can be increased when Efonidipine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Famphur is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "The risk or severity of QTc prolongation can be increased when Fenthion is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Phosmet is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Bilastine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The risk or severity of QTc prolongation can be increased when Talinolol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The risk or severity of QTc prolongation can be increased when Anisodamine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when CUDC 907 is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Temefos is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Givinostat is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The risk or severity of QTc prolongation can be increased when Acetyldigoxin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "The risk or severity of QTc prolongation can be increased when Inotersen is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The risk or severity of QTc prolongation can be increased when Ebastine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The risk or severity of QTc prolongation can be increased when Losartan is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Nitrendipine"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The risk or severity of QTc prolongation can be increased when Isradipine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The risk or severity of QTc prolongation can be increased when Digoxin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The metabolism of Quinine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The metabolism of Nilotinib can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The metabolism of Lumefantrine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The metabolism of Panobinostat can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Fluvoxamine"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Venlafaxine"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Clobazam"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Clozapine"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Imipramine"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Duloxetine"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Chlorpromazine"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Tranylcypromine"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The metabolism of Desipramine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "The metabolism of Vilazodone can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The metabolism of Dosulepin can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The metabolism of Ritanserin can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The metabolism of Cyclosporine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Primaquine"
                    },
                    {
                        "drugbank-id": "DB09291",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Rolapitant"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Rucaparib"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The metabolism of Tegaserod can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB05812",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Abiraterone"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Nicardipine"
                    },
                    {
                        "drugbank-id": "DB00705",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Delavirdine"
                    },
                    {
                        "drugbank-id": "DB06729",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Sulfaphenazole"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Cimetidine"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Manidipine"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Fusidic acid"
                    },
                    {
                        "drugbank-id": "DB00169",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Cholecalciferol"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Metoprolol"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Celecoxib"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Chloroquine"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Perhexiline"
                    },
                    {
                        "drugbank-id": "DB06819",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Phenylbutyric acid"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Asunaprevir"
                    },
                    {
                        "drugbank-id": "DB13174",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Rhein"
                    },
                    {
                        "drugbank-id": "DB00857",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Terbinafine"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The metabolism of Terfenadine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00496",
                        "description": "The metabolism of Darifenacin can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The metabolism of Tipranavir can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "The metabolism of Lorcaserin can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Berotralstat"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Paroxetine"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "The metabolism of Bupropion can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01012",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Cinacalcet"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Propafenone"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08909",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Glycerol phenylbutyrate"
                    },
                    {
                        "drugbank-id": "DB06595",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Midostaurin"
                    },
                    {
                        "drugbank-id": "DB00042",
                        "description": "The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00083",
                        "description": "The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "The risk or severity of adverse effects can be increased when Baclofen is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The risk or severity of adverse effects can be increased when Amphetamine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00189",
                        "description": "The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00202",
                        "description": "The risk or severity of adverse effects can be increased when Succinylcholine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00228",
                        "description": "The risk or severity of adverse effects can be increased when Enflurane is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "The risk or severity of adverse effects can be increased when Butabarbital is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "The risk or severity of adverse effects can be increased when Butalbital is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of adverse effects can be increased when Atomoxetine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "The risk or severity of adverse effects can be increased when Etomidate is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00306",
                        "description": "The risk or severity of adverse effects can be increased when Talbutal is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "The risk or severity of adverse effects can be increased when Codeine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00327",
                        "description": "The risk or severity of adverse effects can be increased when Hydromorphone is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "The risk or severity of adverse effects can be increased when Thiethylperazine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "The risk or severity of adverse effects can be increased when Palonosetron is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00416",
                        "description": "The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00423",
                        "description": "The risk or severity of adverse effects can be increased when Methocarbamol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00463",
                        "description": "The risk or severity of adverse effects can be increased when Metharbital is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "The risk or severity of adverse effects can be increased when Methohexital is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00494",
                        "description": "The risk or severity of adverse effects can be increased when Entacapone is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00497",
                        "description": "The risk or severity of adverse effects can be increased when Oxycodone is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00514",
                        "description": "The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00565",
                        "description": "The risk or severity of adverse effects can be increased when Cisatracurium is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00579",
                        "description": "The risk or severity of adverse effects can be increased when Mazindol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "The risk or severity of adverse effects can be increased when Lisuride is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "The risk or severity of adverse effects can be increased when Thiopental is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00611",
                        "description": "The risk or severity of adverse effects can be increased when Butorphanol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The risk or severity of adverse effects can be increased when Furazolidone is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00617",
                        "description": "The risk or severity of adverse effects can be increased when Paramethadione is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00645",
                        "description": "The risk or severity of adverse effects can be increased when Dyclonine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00660",
                        "description": "The risk or severity of adverse effects can be increased when Metaxalone is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00662",
                        "description": "The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "The risk or severity of adverse effects can be increased when Sufentanil is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "The risk or severity of adverse effects can be increased when Procaine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00728",
                        "description": "The risk or severity of adverse effects can be increased when Rocuronium is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00732",
                        "description": "The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00737",
                        "description": "The risk or severity of adverse effects can be increased when Meclizine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00754",
                        "description": "The risk or severity of adverse effects can be increased when Ethotoin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of adverse effects can be increased when Dolasetron is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00771",
                        "description": "The risk or severity of adverse effects can be increased when Clidinium is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "The risk or severity of adverse effects can be increased when Propiomazine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "The risk or severity of adverse effects can be increased when Acetazolamide is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00832",
                        "description": "The risk or severity of adverse effects can be increased when Phensuximide is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00844",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00854",
                        "description": "The risk or severity of adverse effects can be increased when Levorphanol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "The risk or severity of adverse effects can be increased when Benzphetamine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "The risk or severity of adverse effects can be increased when Alprenolol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of adverse effects can be increased when Granisetron is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The risk or severity of adverse effects can be increased when Remifentanil is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00906",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Tiagabine"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Almotriptan"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Diethylpropion"
                    },
                    {
                        "drugbank-id": "DB00941",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Hexafluronium"
                    },
                    {
                        "drugbank-id": "DB00952",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Naratriptan"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Rizatriptan"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Pindolol"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Zaleplon"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Guanfacine"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Methoxyflurane"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01063",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Acetophenazine"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Clonazepam"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Diphenhydramine"
                    },
                    {
                        "drugbank-id": "DB01080",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Vigabatrin"
                    },
                    {
                        "drugbank-id": "DB01081",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Diphenoxylate"
                    },
                    {
                        "drugbank-id": "DB01107",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Methyprylon"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Chlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01121",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Phenacemide"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Doxacurium"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Thiamylal"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Halothane"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Procarbazine"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Pergolide"
                    },
                    {
                        "drugbank-id": "DB01192",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Oxymorphone"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Tubocurarine"
                    },
                    {
                        "drugbank-id": "DB01209",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Dezocine"
                    },
                    {
                        "drugbank-id": "DB01219",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Dantrolene"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Ketamine"
                    },
                    {
                        "drugbank-id": "DB01226",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Mivacurium"
                    },
                    {
                        "drugbank-id": "DB01235",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Levodopa"
                    },
                    {
                        "drugbank-id": "DB01245",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Decamethonium"
                    },
                    {
                        "drugbank-id": "DB01336",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Metocurine"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Pancuronium"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Pipecuronium"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Amobarbital"
                    },
                    {
                        "drugbank-id": "DB01352",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Aprobarbital"
                    },
                    {
                        "drugbank-id": "DB01353",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Butobarbital"
                    },
                    {
                        "drugbank-id": "DB01354",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Heptabarbital"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Hexobarbital"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Penbutolol"
                    },
                    {
                        "drugbank-id": "DB01433",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Methadyl acetate"
                    },
                    {
                        "drugbank-id": "DB01440",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with gamma Hydroxybutyric acid"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with MMDA"
                    },
                    {
                        "drugbank-id": "DB01450",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Dihydroetorphine"
                    },
                    {
                        "drugbank-id": "DB01452",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Diamorphine"
                    },
                    {
                        "drugbank-id": "DB01466",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Ethylmorphine"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Barbital"
                    },
                    {
                        "drugbank-id": "DB01489",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Camazepam"
                    },
                    {
                        "drugbank-id": "DB01495",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Dichloralphenazone"
                    },
                    {
                        "drugbank-id": "DB01497",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Etorphine"
                    },
                    {
                        "drugbank-id": "DB01501",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Difenoxin"
                    },
                    {
                        "drugbank-id": "DB01511",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Delorazepam"
                    },
                    {
                        "drugbank-id": "DB01529",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Dextromoramide"
                    },
                    {
                        "drugbank-id": "DB01531",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Desomorphine"
                    },
                    {
                        "drugbank-id": "DB01534",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Chlorhexadol"
                    },
                    {
                        "drugbank-id": "DB01535",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Carfentanil"
                    },
                    {
                        "drugbank-id": "DB01547",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Drotebanol"
                    },
                    {
                        "drugbank-id": "DB01551",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Dihydrocodeine"
                    },
                    {
                        "drugbank-id": "DB01553",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Cloxazolam"
                    },
                    {
                        "drugbank-id": "DB01555",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Alphacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01559",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Clotiazepam"
                    },
                    {
                        "drugbank-id": "DB01563",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Chloral hydrate"
                    },
                    {
                        "drugbank-id": "DB01565",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Dihydromorphine"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Metamfetamine"
                    },
                    {
                        "drugbank-id": "DB01589",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Quazepam"
                    },
                    {
                        "drugbank-id": "DB01594",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Cinolazepam"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Periciazine"
                    },
                    {
                        "drugbank-id": "DB01616",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Alverine"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Thioproperazine"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Pargyline"
                    },
                    {
                        "drugbank-id": "DB02234",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with S Ethylisothiourea"
                    },
                    {
                        "drugbank-id": "DB02852",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Domoic Acid"
                    },
                    {
                        "drugbank-id": "DB04165",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Valpromide"
                    },
                    {
                        "drugbank-id": "DB04819",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Methapyrilene"
                    },
                    {
                        "drugbank-id": "DB04821",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Nomifensine"
                    },
                    {
                        "drugbank-id": "DB04827",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Urethane"
                    },
                    {
                        "drugbank-id": "DB04833",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Methaqualone"
                    },
                    {
                        "drugbank-id": "DB04834",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04885",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Cilansetron"
                    },
                    {
                        "drugbank-id": "DB04888",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Bifeprunox"
                    },
                    {
                        "drugbank-id": "DB04903",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Pagoclone"
                    },
                    {
                        "drugbank-id": "DB04917",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Renzapride"
                    },
                    {
                        "drugbank-id": "DB05227",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with APD791"
                    },
                    {
                        "drugbank-id": "DB05232",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Tetrodotoxin"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Brivaracetam"
                    },
                    {
                        "drugbank-id": "DB05542",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Naronapride"
                    },
                    {
                        "drugbank-id": "DB05562",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Naluzotan"
                    },
                    {
                        "drugbank-id": "DB05607",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with PRX 08066"
                    },
                    {
                        "drugbank-id": "DB05687",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with BL 1020"
                    },
                    {
                        "drugbank-id": "DB05710",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Gantacurium"
                    },
                    {
                        "drugbank-id": "DB06077",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Lumateperone"
                    },
                    {
                        "drugbank-id": "DB06109",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with YKP 1358"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Lacosamide"
                    },
                    {
                        "drugbank-id": "DB06264",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Tolperisone"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Dotarizine"
                    },
                    {
                        "drugbank-id": "DB06458",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Remacemide"
                    },
                    {
                        "drugbank-id": "DB06470",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Clomethiazole"
                    },
                    {
                        "drugbank-id": "DB06527",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Tramiprosate"
                    },
                    {
                        "drugbank-id": "DB06529",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Ocinaplon"
                    },
                    {
                        "drugbank-id": "DB06554",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Gaboxadol"
                    },
                    {
                        "drugbank-id": "DB06660",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Saredutant"
                    },
                    {
                        "drugbank-id": "DB06690",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Nitrous oxide"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Dexmethylphenidate"
                    },
                    {
                        "drugbank-id": "DB06716",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Fospropofol"
                    },
                    {
                        "drugbank-id": "DB06738",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Ketobemidone"
                    },
                    {
                        "drugbank-id": "DB06753",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Triclofos"
                    },
                    {
                        "drugbank-id": "DB06797",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Mebutamate"
                    },
                    {
                        "drugbank-id": "DB08059",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Wortmannin"
                    },
                    {
                        "drugbank-id": "DB08329",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Sulthiame"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with 7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline"
                    },
                    {
                        "drugbank-id": "DB08810",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Cinitapride"
                    },
                    {
                        "drugbank-id": "DB08839",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Serotonin"
                    },
                    {
                        "drugbank-id": "DB08861",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with DPDPE"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Gabapentin enacarbil"
                    },
                    {
                        "drugbank-id": "DB08892",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Arbaclofen Placarbil"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Ifenprodil"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Dimetacrine"
                    },
                    {
                        "drugbank-id": "DB09000",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Cyamemazine"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Barbexaclone"
                    },
                    {
                        "drugbank-id": "DB09011",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Beclamide"
                    },
                    {
                        "drugbank-id": "DB09014",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Captodiame"
                    },
                    {
                        "drugbank-id": "DB09017",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Brotizolam"
                    },
                    {
                        "drugbank-id": "DB09021",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Benzoctamine"
                    },
                    {
                        "drugbank-id": "DB09119",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Eslicarbazepine acetate"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Brexpiprazole"
                    },
                    {
                        "drugbank-id": "DB09174",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Lofentanil"
                    },
                    {
                        "drugbank-id": "DB09184",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Edivoxetine"
                    },
                    {
                        "drugbank-id": "DB09186",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Nisoxetine"
                    },
                    {
                        "drugbank-id": "DB09187",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Lortalamine"
                    },
                    {
                        "drugbank-id": "DB09190",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Talopram"
                    },
                    {
                        "drugbank-id": "DB09194",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Etoperidone"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Blonanserin"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Hydracarbazine"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Benmoxin"
                    },
                    {
                        "drugbank-id": "DB09247",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Iproclozide"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Mebanazine"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Octamoxin"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Pheniprazine"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Phenoxypropazine"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Pivhydrazine"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Safrazine"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Caroxazone"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Opium"
                    },
                    {
                        "drugbank-id": "DB11156",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Pyrantel"
                    },
                    {
                        "drugbank-id": "DB11371",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Alfaxalone"
                    },
                    {
                        "drugbank-id": "DB11400",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Doramectin"
                    },
                    {
                        "drugbank-id": "DB11428",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Medetomidine"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Xylazine"
                    },
                    {
                        "drugbank-id": "DB11540",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Propiopromazine"
                    },
                    {
                        "drugbank-id": "DB11543",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Romifidine"
                    },
                    {
                        "drugbank-id": "DB11549",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Tiletamine"
                    },
                    {
                        "drugbank-id": "DB11552",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Tricaine"
                    },
                    {
                        "drugbank-id": "DB11556",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Detomidine"
                    },
                    {
                        "drugbank-id": "DB11582",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Thiocolchicoside"
                    },
                    {
                        "drugbank-id": "DB11609",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Normethadone"
                    },
                    {
                        "drugbank-id": "DB11675",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Mosapride"
                    },
                    {
                        "drugbank-id": "DB11686",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Iferanserin"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Tropisetron"
                    },
                    {
                        "drugbank-id": "DB11755",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11859",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Brexanolone"
                    },
                    {
                        "drugbank-id": "DB11868",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Etiracetam"
                    },
                    {
                        "drugbank-id": "DB11889",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Lanicemine"
                    },
                    {
                        "drugbank-id": "DB11957",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Idalopirdine"
                    },
                    {
                        "drugbank-id": "DB12071",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Vabicaserin"
                    },
                    {
                        "drugbank-id": "DB12105",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Imagabalin"
                    },
                    {
                        "drugbank-id": "DB12110",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with m Chlorophenylpiperazine"
                    },
                    {
                        "drugbank-id": "DB12111",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with MK 212"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Vinpocetine"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Sarpogrelate"
                    },
                    {
                        "drugbank-id": "DB12177",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Eplivanserin"
                    },
                    {
                        "drugbank-id": "DB12229",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Cerlapirdine"
                    },
                    {
                        "drugbank-id": "DB12308",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Eltanolone"
                    },
                    {
                        "drugbank-id": "DB12338",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Carisbamate"
                    },
                    {
                        "drugbank-id": "DB12361",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Piclozotan"
                    },
                    {
                        "drugbank-id": "DB12395",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Esreboxetine"
                    },
                    {
                        "drugbank-id": "DB12427",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Orvepitant"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12492",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Piritramide"
                    },
                    {
                        "drugbank-id": "DB12537",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Benzodiazepine"
                    },
                    {
                        "drugbank-id": "DB12576",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with AZD 3043"
                    },
                    {
                        "drugbank-id": "DB12590",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Indiplon"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Urapidil"
                    },
                    {
                        "drugbank-id": "DB12725",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with TD 8954"
                    },
                    {
                        "drugbank-id": "DB12883",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Eltoprazine"
                    },
                    {
                        "drugbank-id": "DB12951",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Pivagabine"
                    },
                    {
                        "drugbank-id": "DB12958",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Prothipendyl"
                    },
                    {
                        "drugbank-id": "DB12989",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Neosaxitoxin"
                    },
                    {
                        "drugbank-id": "DB13099",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Valnoctamide"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Amitriptylinoxide"
                    },
                    {
                        "drugbank-id": "DB13160",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Alphaprodine"
                    },
                    {
                        "drugbank-id": "DB13213",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Butaperazine"
                    },
                    {
                        "drugbank-id": "DB13219",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Medifoxamine"
                    },
                    {
                        "drugbank-id": "DB13221",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Apronalide"
                    },
                    {
                        "drugbank-id": "DB13234",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Propanidid"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Quinupramine"
                    },
                    {
                        "drugbank-id": "DB13253",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Proxibarbal"
                    },
                    {
                        "drugbank-id": "DB13295",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Atracurium"
                    },
                    {
                        "drugbank-id": "DB13303",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Febarbamate"
                    },
                    {
                        "drugbank-id": "DB13323",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Trichloroethylene"
                    },
                    {
                        "drugbank-id": "DB13324",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Tetrazepam"
                    },
                    {
                        "drugbank-id": "DB13331",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Pyrithyldione"
                    },
                    {
                        "drugbank-id": "DB13354",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Phenprobamate"
                    },
                    {
                        "drugbank-id": "DB13357",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Styramate"
                    },
                    {
                        "drugbank-id": "DB13362",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Pheneturide"
                    },
                    {
                        "drugbank-id": "DB13370",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Bromisoval"
                    },
                    {
                        "drugbank-id": "DB13377",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Vinbarbital"
                    },
                    {
                        "drugbank-id": "DB13382",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Chlorproethazine"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Melitracen"
                    },
                    {
                        "drugbank-id": "DB13396",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Neocitrullamon"
                    },
                    {
                        "drugbank-id": "DB13402",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Acetylglycinamide chloral hydrate"
                    },
                    {
                        "drugbank-id": "DB13403",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Oxypertine"
                    },
                    {
                        "drugbank-id": "DB13414",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Fenyramidol"
                    },
                    {
                        "drugbank-id": "DB13420",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Thiazinam"
                    },
                    {
                        "drugbank-id": "DB13457",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Oxaflozane"
                    },
                    {
                        "drugbank-id": "DB13478",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Meptazinol"
                    },
                    {
                        "drugbank-id": "DB13505",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Emepronium"
                    },
                    {
                        "drugbank-id": "DB13520",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Metergoline"
                    },
                    {
                        "drugbank-id": "DB13534",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Gedocarnil"
                    },
                    {
                        "drugbank-id": "DB13541",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Iprazochrome"
                    },
                    {
                        "drugbank-id": "DB13554",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Moperone"
                    },
                    {
                        "drugbank-id": "DB13557",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Thiopropazate"
                    },
                    {
                        "drugbank-id": "DB13572",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Emylcamate"
                    },
                    {
                        "drugbank-id": "DB13577",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Allobarbital"
                    },
                    {
                        "drugbank-id": "DB13584",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Gallamine"
                    },
                    {
                        "drugbank-id": "DB13588",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Naftidrofuryl"
                    },
                    {
                        "drugbank-id": "DB13605",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Phenoperidine"
                    },
                    {
                        "drugbank-id": "DB13606",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Phenazocine"
                    },
                    {
                        "drugbank-id": "DB13623",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Fabomotizole"
                    },
                    {
                        "drugbank-id": "DB13642",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Pridinol"
                    },
                    {
                        "drugbank-id": "DB13648",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Alcuronium"
                    },
                    {
                        "drugbank-id": "DB13662",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Hexapropymate"
                    },
                    {
                        "drugbank-id": "DB13676",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Mosapramine"
                    },
                    {
                        "drugbank-id": "DB13687",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Niaprazine"
                    },
                    {
                        "drugbank-id": "DB13690",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Vinyl ether"
                    },
                    {
                        "drugbank-id": "DB13733",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Methylpentynol"
                    },
                    {
                        "drugbank-id": "DB13737",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Cyclobarbital"
                    },
                    {
                        "drugbank-id": "DB13745",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Fazadinium bromide"
                    },
                    {
                        "drugbank-id": "DB13754",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Mephenoxalone"
                    },
                    {
                        "drugbank-id": "DB13770",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Vinylbital"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Imipramine oxide"
                    },
                    {
                        "drugbank-id": "DB13787",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Tilidine"
                    },
                    {
                        "drugbank-id": "DB13799",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Ethadione"
                    },
                    {
                        "drugbank-id": "DB13805",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Reposal"
                    },
                    {
                        "drugbank-id": "DB13817",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Carbromal"
                    },
                    {
                        "drugbank-id": "DB13837",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Doxefazepam"
                    },
                    {
                        "drugbank-id": "DB13872",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Lormetazepam"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Harmaline"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Brofaromine"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with 2 5 Dimethoxy 4 ethylthioamphetamine"
                    },
                    {
                        "drugbank-id": "DB13948",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with N 2 hydroxybenzyl 2 5 dimethoxy 4 cyanophenylethylamine"
                    },
                    {
                        "drugbank-id": "DB13984",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Cyclopropane"
                    },
                    {
                        "drugbank-id": "DB13993",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with MRK 409"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with 5 methoxy N N dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB14050",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Cannabidivarin"
                    },
                    {
                        "drugbank-id": "DB14575",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Eslicarbazepine"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Perphenazine enanthate"
                    },
                    {
                        "drugbank-id": "DB14672",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Oxazepam acetate"
                    },
                    {
                        "drugbank-id": "DB14715",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Cinazepam"
                    },
                    {
                        "drugbank-id": "DB14718",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Pyrazolam"
                    },
                    {
                        "drugbank-id": "DB14719",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Bentazepam"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Solriamfetol"
                    },
                    {
                        "drugbank-id": "DB15203",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with JNJ 26489112"
                    },
                    {
                        "drugbank-id": "DB15360",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Carfentanil C 11"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01437",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Glutethimide"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The risk or severity of adverse effects can be increased when Primidone is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "The risk or severity of adverse effects can be increased when Methysergide is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "The risk or severity of adverse effects can be increased when Pentobarbital is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "The risk or severity of adverse effects can be increased when Secobarbital is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with St John s Wort"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Lemborexant"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "The risk or severity of adverse effects can be increased when Eletriptan is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of adverse effects can be increased when Propofol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "The risk or severity of adverse effects can be increased when Donepezil is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The risk or severity of adverse effects can be increased when Cabergoline is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "The risk or severity of adverse effects can be increased when Topiramate is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The risk or severity of adverse effects can be increased when Morphine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00652",
                        "description": "The risk or severity of adverse effects can be increased when Pentazocine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "The risk or severity of adverse effects can be increased when Sumatriptan is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "The risk or severity of adverse effects can be increased when Ergotamine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Zonisamide"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Desloratadine"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Bromocriptine"
                    },
                    {
                        "drugbank-id": "DB01202",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Levetiracetam"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Ergometrine"
                    },
                    {
                        "drugbank-id": "DB01339",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Vecuronium"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Flibanserin"
                    },
                    {
                        "drugbank-id": "DB06770",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Benzyl alcohol"
                    },
                    {
                        "drugbank-id": "DB13598",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Diethyl ether"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of adverse effects can be increased when Protriptyline is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The risk or severity of adverse effects can be increased when Meperidine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "The risk or severity of adverse effects can be increased when Mephenytoin is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The risk or severity of adverse effects can be increased when Alfentanil is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The risk or severity of adverse effects can be increased when Fentanyl is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Opipramol"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Ziconotide"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00197",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Troglitazone"
                    },
                    {
                        "drugbank-id": "DB01138",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Sulfinpyrazone"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Medical Cannabis"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The metabolism of Ondansetron can be increased when combined with Dabrafenib"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Fluconazole"
                    },
                    {
                        "drugbank-id": "DB00322",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Floxuridine"
                    },
                    {
                        "drugbank-id": "DB01110",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Miconazole"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Gemfibrozil"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The therapeutic efficacy of Ondansetron can be increased when used in combination with Pregabalin"
                    },
                    {
                        "drugbank-id": "DB00150",
                        "description": "The risk or severity of adverse effects can be increased when Tryptophan is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "The risk or severity of adverse effects can be increased when Lorazepam is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The risk or severity of adverse effects can be increased when Reserpine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00231",
                        "description": "The risk or severity of adverse effects can be increased when Temazepam is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00234",
                        "description": "The risk or severity of adverse effects can be increased when Reboxetine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of adverse effects can be increased when Olanzapine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00371",
                        "description": "The risk or severity of adverse effects can be increased when Meprobamate is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of adverse effects can be increased when Sulpiride is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "The risk or severity of adverse effects can be increased when Alprazolam is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "The risk or severity of adverse effects can be increased when Loxapine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00409",
                        "description": "The risk or severity of adverse effects can be increased when Remoxipride is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of adverse effects can be increased when Promazine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00475",
                        "description": "The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "The risk or severity of adverse effects can be increased when Triflupromazine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00546",
                        "description": "The risk or severity of adverse effects can be increased when Adinazolam is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of adverse effects can be increased when Lamotrigine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "The risk or severity of adverse effects can be increased when Midazolam is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00690",
                        "description": "The risk or severity of adverse effects can be increased when Flurazepam is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of adverse effects can be increased when Risperidone is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The risk or severity of adverse effects can be increased when Phenelzine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00801",
                        "description": "The risk or severity of adverse effects can be increased when Halazepam is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The risk or severity of adverse effects can be increased when Minaprine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "The risk or severity of adverse effects can be increased when Diazepam is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00837",
                        "description": "The risk or severity of adverse effects can be increased when Progabide is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00842",
                        "description": "The risk or severity of adverse effects can be increased when Oxazepam is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "The risk or severity of adverse effects can be increased when Perphenazine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "The risk or severity of adverse effects can be increased when Triazolam is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00996",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Gabapentin"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Selegiline"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Moclobemide"
                    },
                    {
                        "drugbank-id": "DB01178",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Chlormezanone"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Estazolam"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Quetiapine"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Aripiprazole"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Chlorprothixene"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Isocarboxazid"
                    },
                    {
                        "drugbank-id": "DB01445",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Bufotenine"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Midomafetamine"
                    },
                    {
                        "drugbank-id": "DB01463",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Fencamfamin"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with 4 Methoxyamphetamine"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with 4 Bromo 2 5 dimethoxyamphetamine"
                    },
                    {
                        "drugbank-id": "DB01488",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Tenamfetamine"
                    },
                    {
                        "drugbank-id": "DB01544",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Flunitrazepam"
                    },
                    {
                        "drugbank-id": "DB01545",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Ethyl loflazepate"
                    },
                    {
                        "drugbank-id": "DB01558",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Bromazepam"
                    },
                    {
                        "drugbank-id": "DB01560",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Cathinone"
                    },
                    {
                        "drugbank-id": "DB01567",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Fludiazepam"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Ketazolam"
                    },
                    {
                        "drugbank-id": "DB01588",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Prazepam"
                    },
                    {
                        "drugbank-id": "DB01595",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Nitrazepam"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Acepromazine"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB01618",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Molindone"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Thiothixene"
                    },
                    {
                        "drugbank-id": "DB01954",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Rolipram"
                    },
                    {
                        "drugbank-id": "DB02207",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with 7 Nitroindazole"
                    },
                    {
                        "drugbank-id": "DB02959",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Oxitriptan"
                    },
                    {
                        "drugbank-id": "DB03575",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Phencyclidine"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Clorgiline"
                    },
                    {
                        "drugbank-id": "DB04325",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Phenethylamine"
                    },
                    {
                        "drugbank-id": "DB04599",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Aniracetam"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Iproniazid"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Nialamide"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Lysergic acid diethylamide"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Amineptine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB04872",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Osanetant"
                    },
                    {
                        "drugbank-id": "DB05316",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Pimavanserin"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Cariprazine"
                    },
                    {
                        "drugbank-id": "DB06144",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Sertindole"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Mianserin"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Pizotifen"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Amisulpride"
                    },
                    {
                        "drugbank-id": "DB06512",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Deramciclane"
                    },
                    {
                        "drugbank-id": "DB06579",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Adipiplon"
                    },
                    {
                        "drugbank-id": "DB06582",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Dextofisopam"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Esmirtazapine"
                    },
                    {
                        "drugbank-id": "DB08811",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Tofisopam"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Lurasidone"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Perospirone"
                    },
                    {
                        "drugbank-id": "DB08927",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Amperozide"
                    },
                    {
                        "drugbank-id": "DB08986",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Etifoxine"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09023",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Benactyzine"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Vortioxetine"
                    },
                    {
                        "drugbank-id": "DB09166",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Etizolam"
                    },
                    {
                        "drugbank-id": "DB09185",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Viloxazine"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Melperone"
                    },
                    {
                        "drugbank-id": "DB09225",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Zotepine"
                    },
                    {
                        "drugbank-id": "DB09226",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Brilaroxazine"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Pirlindole"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Toloxatone"
                    },
                    {
                        "drugbank-id": "DB09286",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Pipamperone"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Tianeptine"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Oxaprotiline"
                    },
                    {
                        "drugbank-id": "DB11376",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Azaperone"
                    },
                    {
                        "drugbank-id": "DB11555",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Zolazepam"
                    },
                    {
                        "drugbank-id": "DB11664",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Psilocybin"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB12184",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Gepirone"
                    },
                    {
                        "drugbank-id": "DB12273",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Ecopipam"
                    },
                    {
                        "drugbank-id": "DB12327",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Salvinorin A"
                    },
                    {
                        "drugbank-id": "DB12401",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Bromperidol"
                    },
                    {
                        "drugbank-id": "DB12518",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Raclopride"
                    },
                    {
                        "drugbank-id": "DB12710",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Perazine"
                    },
                    {
                        "drugbank-id": "DB12833",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Tandospirone"
                    },
                    {
                        "drugbank-id": "DB12867",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Benperidol"
                    },
                    {
                        "drugbank-id": "DB13014",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Hypericin"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Tiapride"
                    },
                    {
                        "drugbank-id": "DB13082",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Nefiracetam"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Dibenzepin"
                    },
                    {
                        "drugbank-id": "DB13256",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Clothiapine"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13335",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Pinazepam"
                    },
                    {
                        "drugbank-id": "DB13352",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Deanol"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Lofepramine"
                    },
                    {
                        "drugbank-id": "DB13437",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Medazepam"
                    },
                    {
                        "drugbank-id": "DB13455",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Phenibut"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Iprindole"
                    },
                    {
                        "drugbank-id": "DB13522",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Mebicar"
                    },
                    {
                        "drugbank-id": "DB13523",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Veralipride"
                    },
                    {
                        "drugbank-id": "DB13550",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Bifemelane"
                    },
                    {
                        "drugbank-id": "DB13552",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Trifluperidol"
                    },
                    {
                        "drugbank-id": "DB13601",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Oxiracetam"
                    },
                    {
                        "drugbank-id": "DB13643",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Loprazolam"
                    },
                    {
                        "drugbank-id": "DB13665",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Fluanisone"
                    },
                    {
                        "drugbank-id": "DB13784",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Dixyrazine"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB13841",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Clopenthixol"
                    },
                    {
                        "drugbank-id": "DB14028",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Nordazepam"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Aripiprazole lauroxil"
                    },
                    {
                        "drugbank-id": "DB14509",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Lithium carbonate"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "Ondansetron may increase the QTc prolonging activities of Delamanid"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The serum concentration of Ondansetron can be decreased when it is combined with Pitolisant"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The therapeutic efficacy of Ondansetron can be increased when used in combination with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB09046",
                        "description": "The metabolism of Ondansetron can be increased when combined with Metreleptin"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB08873",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Boceprevir"
                    },
                    {
                        "drugbank-id": "DB09065",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Cobicistat"
                    },
                    {
                        "drugbank-id": "DB13179",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Troleandomycin"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The metabolism of Saquinavir can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Nelfinavir"
                    },
                    {
                        "drugbank-id": "DB06448",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Lonafarnib"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Voriconazole"
                    },
                    {
                        "drugbank-id": "DB00673",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Aprepitant"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Telithromycin"
                    },
                    {
                        "drugbank-id": "DB02520",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Ditiocarb"
                    },
                    {
                        "drugbank-id": "DB06412",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Oxymetholone"
                    },
                    {
                        "drugbank-id": "DB14635",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Curcumin sulfate"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08906",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Fluticasone furoate"
                    },
                    {
                        "drugbank-id": "DB11574",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Elbasvir"
                    },
                    {
                        "drugbank-id": "DB12070",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Letermovir"
                    },
                    {
                        "drugbank-id": "DB13867",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Fluticasone"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Clofazimine"
                    },
                    {
                        "drugbank-id": "DB15822",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Pralsetinib"
                    },
                    {
                        "drugbank-id": "DB11703",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Acalabrutinib"
                    },
                    {
                        "drugbank-id": "DB00224",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Indinavir"
                    },
                    {
                        "drugbank-id": "DB11837",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Osilodrostat"
                    },
                    {
                        "drugbank-id": "DB11737",
                        "description": "The metabolism of Ondansetron can be increased when combined with Icotinib"
                    },
                    {
                        "drugbank-id": "DB00745",
                        "description": "The metabolism of Ondansetron can be increased when combined with Modafinil"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The metabolism of Ondansetron can be increased when combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "The metabolism of Ondansetron can be increased when combined with Budesonide"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The metabolism of Ondansetron can be increased when combined with Dexamethasone"
                    },
                    {
                        "drugbank-id": "DB00394",
                        "description": "The metabolism of Ondansetron can be increased when combined with Beclomethasone dipropionate"
                    },
                    {
                        "drugbank-id": "DB06413",
                        "description": "The metabolism of Ondansetron can be increased when combined with Armodafinil"
                    },
                    {
                        "drugbank-id": "DB00776",
                        "description": "The metabolism of Ondansetron can be increased when combined with Oxcarbazepine"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The metabolism of Ondansetron can be increased when combined with Triamcinolone"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The metabolism of Ondansetron can be increased when combined with Cortisone acetate"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "The metabolism of Ondansetron can be increased when combined with Paramethasone"
                    },
                    {
                        "drugbank-id": "DB08970",
                        "description": "The metabolism of Ondansetron can be increased when combined with Fluprednidene"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "The metabolism of Ondansetron can be increased when combined with Meprednisone"
                    },
                    {
                        "drugbank-id": "DB11487",
                        "description": "The metabolism of Ondansetron can be increased when combined with Dexamethasone isonicotinate"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "The metabolism of Ondansetron can be increased when combined with Deflazacort"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "The metabolism of Ondansetron can be increased when combined with Cortivazol"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "The metabolism of Ondansetron can be increased when combined with Prednylidene"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "The metabolism of Ondansetron can be increased when combined with Cloprednol"
                    },
                    {
                        "drugbank-id": "DB14512",
                        "description": "The metabolism of Ondansetron can be increased when combined with Mometasone furoate"
                    },
                    {
                        "drugbank-id": "DB14631",
                        "description": "The metabolism of Ondansetron can be increased when combined with Prednisolone phosphate"
                    },
                    {
                        "drugbank-id": "DB14633",
                        "description": "The metabolism of Ondansetron can be increased when combined with Prednisolone hemisuccinate"
                    },
                    {
                        "drugbank-id": "DB14644",
                        "description": "The metabolism of Ondansetron can be increased when combined with Methylprednisolone hemisuccinate"
                    },
                    {
                        "drugbank-id": "DB14646",
                        "description": "The metabolism of Ondansetron can be increased when combined with Prednisone acetate"
                    },
                    {
                        "drugbank-id": "DB14652",
                        "description": "The metabolism of Ondansetron can be increased when combined with Clocortolone acetate"
                    },
                    {
                        "drugbank-id": "DB14659",
                        "description": "The metabolism of Ondansetron can be increased when combined with Melengestrol acetate"
                    },
                    {
                        "drugbank-id": "DB14669",
                        "description": "The metabolism of Ondansetron can be increased when combined with Betamethasone phosphate"
                    },
                    {
                        "drugbank-id": "DB14681",
                        "description": "The metabolism of Ondansetron can be increased when combined with Cortisone"
                    },
                    {
                        "drugbank-id": "DB00694",
                        "description": "The metabolism of Ondansetron can be increased when combined with Daunorubicin"
                    },
                    {
                        "drugbank-id": "DB01013",
                        "description": "The metabolism of Ondansetron can be increased when combined with Clobetasol propionate"
                    },
                    {
                        "drugbank-id": "DB01047",
                        "description": "The metabolism of Ondansetron can be increased when combined with Fluocinonide"
                    },
                    {
                        "drugbank-id": "DB00764",
                        "description": "The metabolism of Ondansetron can be increased when combined with Mometasone"
                    },
                    {
                        "drugbank-id": "DB08971",
                        "description": "The metabolism of Ondansetron can be increased when combined with Fluocortolone"
                    },
                    {
                        "drugbank-id": "DB11750",
                        "description": "The metabolism of Ondansetron can be increased when combined with Clobetasol"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "The metabolism of Ondansetron can be increased when combined with Difluocortolone"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The metabolism of Ondansetron can be increased when combined with Betamethasone"
                    },
                    {
                        "drugbank-id": "DB12130",
                        "description": "The metabolism of Lorlatinib can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01126",
                        "description": "The metabolism of Dutasteride can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00250",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Dapsone"
                    },
                    {
                        "drugbank-id": "DB00367",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Levonorgestrel"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Eplerenone"
                    },
                    {
                        "drugbank-id": "DB00717",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Norethisterone"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Nateglinide"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Tretinoin"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Tadalafil"
                    },
                    {
                        "drugbank-id": "DB01216",
                        "description": "The metabolism of Finasteride can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06267",
                        "description": "The metabolism of Udenafil can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06335",
                        "description": "The metabolism of Saxagliptin can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06419",
                        "description": "The metabolism of Cethromycin can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06652",
                        "description": "The metabolism of Vicriviroc can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06789",
                        "description": "The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The metabolism of Ibrutinib can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11915",
                        "description": "The metabolism of Valbenazine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB12301",
                        "description": "The metabolism of Doravirine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB14539",
                        "description": "The metabolism of Hydrocortisone acetate can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB14541",
                        "description": "The metabolism of Hydrocortisone cypionate can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB15444",
                        "description": "The metabolism of Elexacaftor can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "The metabolism of Rosuvastatin can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09237",
                        "description": "The metabolism of Levamlodipine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Nisoldipine"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Mycophenolate mofetil"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Hydrocortisone"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Irinotecan"
                    },
                    {
                        "drugbank-id": "DB01076",
                        "description": "The metabolism of Atorvastatin can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01103",
                        "description": "The metabolism of Quinacrine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01190",
                        "description": "The metabolism of Clindamycin can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB05521",
                        "description": "The metabolism of Telaprevir can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "The metabolism of Rivaroxaban can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "The metabolism of Ambrisentan can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB08820",
                        "description": "The metabolism of Ivacaftor can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09102",
                        "description": "The metabolism of Daclatasvir can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09297",
                        "description": "The metabolism of Paritaprevir can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11712",
                        "description": "The metabolism of Tezacaftor can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB14540",
                        "description": "The metabolism of Hydrocortisone butyrate can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB14542",
                        "description": "The metabolism of Hydrocortisone phosphate can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The metabolism of Erlotinib can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Carbamazepine"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The metabolism of Pimozide can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The metabolism of Tacrolimus can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The metabolism of Sirolimus can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The metabolism of Paclitaxel can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The metabolism of Temsirolimus can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The metabolism of Astemizole can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06626",
                        "description": "The metabolism of Axitinib can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09256",
                        "description": "The metabolism of Tegafur can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Cyclophosphamide"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The metabolism of Ifosfamide can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Teniposide"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The metabolism of Etoposide can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The metabolism of Dasatinib can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Vincristine"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The metabolism of Docetaxel can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The metabolism of Trastuzumab emtansine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The metabolism of Cabazitaxel can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The metabolism of Ponatinib can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "The metabolism of Olaparib can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB12483",
                        "description": "The metabolism of Copanlisib can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Diltiazem"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Itraconazole"
                    },
                    {
                        "drugbank-id": "DB00446",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Chloramphenicol"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Mibefradil"
                    },
                    {
                        "drugbank-id": "DB06730",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Gestodene"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "The metabolism of Ondansetron can be increased when combined with Rifampicin"
                    },
                    {
                        "drugbank-id": "DB05804",
                        "description": "The metabolism of Prasterone sulfate can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The metabolism of Quinidine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The metabolism of Everolimus can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The metabolism of Rilpivirine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Ticlopidine"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Rosiglitazone"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Labetalol"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Dexmedetomidine"
                    },
                    {
                        "drugbank-id": "DB00792",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Tripelennamine"
                    },
                    {
                        "drugbank-id": "DB00810",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Biperiden"
                    },
                    {
                        "drugbank-id": "DB01005",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Hydroxyurea"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Oxprenolol"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Pipotiazine"
                    },
                    {
                        "drugbank-id": "DB06727",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Sparteine"
                    },
                    {
                        "drugbank-id": "DB11638",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Artenimol"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Lercanidipine"
                    },
                    {
                        "drugbank-id": "DB01096",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Oxamniquine"
                    },
                    {
                        "drugbank-id": "DB01562",
                        "description": "The metabolism of Ondansetron can be decreased when combined with 1 2 Phenylethyl 4 phenyl 4 acetoxypiperidine"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Levosalbutamol"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "The metabolism of Oxybutynin can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Methimazole"
                    },
                    {
                        "drugbank-id": "DB01093",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Dimethyl sulfoxide"
                    },
                    {
                        "drugbank-id": "DB06370",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Indisulam"
                    },
                    {
                        "drugbank-id": "DB09049",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Naloxegol"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Stiripentol"
                    },
                    {
                        "drugbank-id": "DB00627",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Niacin"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Doxorubicin"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Hydroxychloroquine"
                    },
                    {
                        "drugbank-id": "DB12500",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Fedratinib"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Vinorelbine"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB04911",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Oritavancin"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Atenolol"
                    },
                    {
                        "drugbank-id": "DB00592",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Piperazine"
                    },
                    {
                        "drugbank-id": "DB00699",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Nicergoline"
                    },
                    {
                        "drugbank-id": "DB00914",
                        "description": "The metabolism of Phenformin can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01295",
                        "description": "The metabolism of Bevantolol can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "The metabolism of Practolol can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01429",
                        "description": "The metabolism of Aprindine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06608",
                        "description": "The metabolism of Tafenoquine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06726",
                        "description": "The metabolism of Bufuralol can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06735",
                        "description": "The metabolism of Enclomiphene can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB08807",
                        "description": "The metabolism of Bopindolol can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "The metabolism of Arotinolol can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09351",
                        "description": "The metabolism of Levobetaxolol can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "The metabolism of Landiolol can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB12752",
                        "description": "The metabolism of Bucindolol can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13443",
                        "description": "The metabolism of Esatenolol can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13508",
                        "description": "The metabolism of Cloranolol can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13530",
                        "description": "The metabolism of Mepindolol can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "The metabolism of Epanolol can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13775",
                        "description": "The metabolism of Tertatolol can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06506",
                        "description": "The metabolism of Repinotan can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09173",
                        "description": "The metabolism of Butyrfentanyl can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00185",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Cevimeline"
                    },
                    {
                        "drugbank-id": "DB00297",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Bupivacaine"
                    },
                    {
                        "drugbank-id": "DB00706",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Tamsulosin"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "The metabolism of Ciclesonide can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "The metabolism of Nebivolol can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06203",
                        "description": "The metabolism of Alogliptin can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09195",
                        "description": "The metabolism of Lorpiprazole can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13293",
                        "description": "The metabolism of Ipecac can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "The metabolism of Nadolol can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB04840",
                        "description": "The metabolism of Debrisoquine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "The metabolism of Tesmilifene can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "The metabolism of Dasabuvir can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11979",
                        "description": "The metabolism of Elagolix can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The metabolism of Sotalol can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The metabolism of Procainamide can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "The metabolism of Flecainide can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The metabolism of Theophylline can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The metabolism of Trabectedin can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Enasidenib"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Amitriptyline"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The metabolism of Nortriptyline can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The metabolism of Amoxapine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Trimipramine"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The metabolism of Clomipramine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00184",
                        "description": "The metabolism of Nicotine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00262",
                        "description": "The metabolism of Carmustine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00286",
                        "description": "The metabolism of Conjugated estrogens can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00296",
                        "description": "The metabolism of Ropivacaine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "The metabolism of Chlorzoxazone can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00379",
                        "description": "The metabolism of Mexiletine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00382",
                        "description": "The metabolism of Tacrine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00384",
                        "description": "The metabolism of Triamterene can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00442",
                        "description": "The metabolism of Entecavir can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "The metabolism of Nabumetone can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00499",
                        "description": "The metabolism of Flutamide can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "The metabolism of Rofecoxib can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "The metabolism of Diclofenac can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00629",
                        "description": "The metabolism of Guanabenz can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "The metabolism of Pemetrexed can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00730",
                        "description": "The metabolism of Thiabendazole can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00740",
                        "description": "The metabolism of Riluzole can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00744",
                        "description": "The metabolism of Zileuton can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00758",
                        "description": "The metabolism of Clopidogrel can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00787",
                        "description": "The metabolism of Acyclovir can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "The metabolism of Naproxen can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "The metabolism of Pentoxifylline can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00969",
                        "description": "The metabolism of Alosetron can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00980",
                        "description": "The metabolism of Ramelteon can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00993",
                        "description": "The metabolism of Azathioprine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00998",
                        "description": "The metabolism of Frovatriptan can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01002",
                        "description": "The metabolism of Levobupivacaine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01056",
                        "description": "The metabolism of Tocainide can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01058",
                        "description": "The metabolism of Praziquantel can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01065",
                        "description": "The metabolism of Melatonin can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01094",
                        "description": "The metabolism of Hesperetin can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01097",
                        "description": "The metabolism of Leflunomide can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01191",
                        "description": "The metabolism of Dexfenfluramine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01303",
                        "description": "The metabolism of Oxtriphylline can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "The metabolism of Rasagiline can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01412",
                        "description": "The metabolism of Theobromine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The metabolism of Aminophenazone can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The metabolism of Antipyrine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01482",
                        "description": "The metabolism of Fenethylline can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "The metabolism of Etoricoxib can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01667",
                        "description": "The metabolism of 8 azaguanine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB02134",
                        "description": "The metabolism of Xanthine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB02489",
                        "description": "The metabolism of 9 Methylguanine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB02568",
                        "description": "The metabolism of Peldesine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB02709",
                        "description": "The metabolism of Resveratrol can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB03783",
                        "description": "The metabolism of Phenacetin can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB04076",
                        "description": "The metabolism of Hypoxanthine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB04356",
                        "description": "The metabolism of 9 Deazaguanine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB04574",
                        "description": "The metabolism of Estrone sulfate can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "The metabolism of Flunarizine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB04951",
                        "description": "The metabolism of Pirfenidone can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06210",
                        "description": "The metabolism of Eltrombopag can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06235",
                        "description": "The metabolism of Vadimezan can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06479",
                        "description": "The metabolism of Propentofylline can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06594",
                        "description": "The metabolism of Agomelatine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06774",
                        "description": "The metabolism of Capsaicin can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The metabolism of R warfarin can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "The metabolism of Tasimelteon can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "The metabolism of Doxofylline can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The metabolism of Propacetamol can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09290",
                        "description": "The metabolism of Ramosetron can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11919",
                        "description": "The metabolism of 6 O benzylguanine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11967",
                        "description": "The metabolism of Binimetinib can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB12406",
                        "description": "The metabolism of Lisofylline can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB12531",
                        "description": "The metabolism of Lobucavir can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB12926",
                        "description": "The metabolism of Cafedrine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB12927",
                        "description": "The metabolism of Theodrenaline can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB12945",
                        "description": "The metabolism of Dihydralazine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13203",
                        "description": "The metabolism of Bamifylline can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13449",
                        "description": "The metabolism of Proxyphylline can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13573",
                        "description": "The metabolism of Acefylline can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13592",
                        "description": "The metabolism of Etamiphylline can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13634",
                        "description": "The metabolism of Pentifylline can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13812",
                        "description": "The metabolism of Bufylline can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB14018",
                        "description": "The metabolism of Bromotheophylline can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB14132",
                        "description": "The metabolism of 8 chlorotheophylline can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "The metabolism of Istradefylline can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB04889",
                        "description": "The metabolism of Bicifadine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB05708",
                        "description": "The metabolism of GTS 21 can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00201",
                        "description": "The metabolism of Caffeine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Verapamil"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Estradiol"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "The metabolism of Ethinylestradiol can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The metabolism of Carvedilol can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "The metabolism of Dapagliflozin can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "The metabolism of Estradiol acetate can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13953",
                        "description": "The metabolism of Estradiol benzoate can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "The metabolism of Estradiol cypionate can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "The metabolism of Estradiol dienanthate can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "The metabolism of Estradiol valerate can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00281",
                        "description": "The metabolism of Lidocaine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "The metabolism of Acetaminophen can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00518",
                        "description": "The metabolism of Albendazole can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "The metabolism of Ranitidine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB12026",
                        "description": "The metabolism of Voxilaprevir can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11689",
                        "description": "The metabolism of Selumetinib can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00655",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Estrone"
                    },
                    {
                        "drugbank-id": "DB00299",
                        "description": "The metabolism of Penciclovir can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The metabolism of Tizanidine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00851",
                        "description": "The metabolism of Dacarbazine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The metabolism of Bendamustine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01223",
                        "description": "The metabolism of Aminophylline can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00559",
                        "description": "The metabolism of Ondansetron can be increased when combined with Bosentan"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "The metabolism of Ondansetron can be increased when combined with Enzalutamide"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The metabolism of Ondansetron can be increased when combined with Peginterferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "The metabolism of Ondansetron can be increased when combined with Apalutamide"
                    },
                    {
                        "drugbank-id": "DB11995",
                        "description": "The metabolism of Ondansetron can be increased when combined with Avatrombopag"
                    },
                    {
                        "drugbank-id": "DB00177",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Valsartan"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Torasemide"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Tolcapone"
                    },
                    {
                        "drugbank-id": "DB00359",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Sulfadiazine"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Cisplatin"
                    },
                    {
                        "drugbank-id": "DB00549",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Zafirlukast"
                    },
                    {
                        "drugbank-id": "DB00576",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Sulfamethizole"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Medroxyprogesterone acetate"
                    },
                    {
                        "drugbank-id": "DB00621",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Oxandrolone"
                    },
                    {
                        "drugbank-id": "DB00665",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Nilutamide"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Epinephrine"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Phenylbutazone"
                    },
                    {
                        "drugbank-id": "DB00891",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Sulfapyridine"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Isoniazid"
                    },
                    {
                        "drugbank-id": "DB01095",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Fluvastatin"
                    },
                    {
                        "drugbank-id": "DB01117",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Atovaquone"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Rabeprazole"
                    },
                    {
                        "drugbank-id": "DB01381",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Ginkgo biloba"
                    },
                    {
                        "drugbank-id": "DB01411",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Pranlukast"
                    },
                    {
                        "drugbank-id": "DB01685",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Topiroxostat"
                    },
                    {
                        "drugbank-id": "DB03756",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Doconexent"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Clevidipine"
                    },
                    {
                        "drugbank-id": "DB06150",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Sulfadimethoxine"
                    },
                    {
                        "drugbank-id": "DB06174",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Noscapine"
                    },
                    {
                        "drugbank-id": "DB06268",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Sitaxentan"
                    },
                    {
                        "drugbank-id": "DB06442",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Avasimibe"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Safinamide"
                    },
                    {
                        "drugbank-id": "DB08798",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Sulfamoxole"
                    },
                    {
                        "drugbank-id": "DB08828",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Vismodegib"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Ceritinib"
                    },
                    {
                        "drugbank-id": "DB09198",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Lobeglitazone"
                    },
                    {
                        "drugbank-id": "DB11994",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Diacerein"
                    },
                    {
                        "drugbank-id": "DB12319",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Benzbromarone"
                    },
                    {
                        "drugbank-id": "DB13975",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Black cohosh"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The metabolism of Lovastatin can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The metabolism of Felodipine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB04856",
                        "description": "The metabolism of Dexloxiglumide can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Tienilic acid"
                    },
                    {
                        "drugbank-id": "DB00238",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Nevirapine"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Probenecid"
                    },
                    {
                        "drugbank-id": "DB06414",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Etravirine"
                    },
                    {
                        "drugbank-id": "DB00255",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Diethylstilbestrol"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Gefitinib"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Progesterone"
                    },
                    {
                        "drugbank-id": "DB00439",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Cerivastatin"
                    },
                    {
                        "drugbank-id": "DB00448",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Lansoprazole"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Amodiaquine"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Simvastatin"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Metronidazole"
                    },
                    {
                        "drugbank-id": "DB01016",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Glyburide"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Fenofibrate"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Promethazine"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Atazanavir"
                    },
                    {
                        "drugbank-id": "DB01128",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Bicalutamide"
                    },
                    {
                        "drugbank-id": "DB01645",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Genistein"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Regorafenib"
                    },
                    {
                        "drugbank-id": "DB09280",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Lumacaftor"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Isavuconazole"
                    },
                    {
                        "drugbank-id": "DB11753",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Rifamycin"
                    },
                    {
                        "drugbank-id": "DB14033",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Acetyl sulfisoxazole"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Valdecoxib"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Sildenafil"
                    },
                    {
                        "drugbank-id": "DB13919",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Candesartan"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Ticagrelor"
                    },
                    {
                        "drugbank-id": "DB00222",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Glimepiride"
                    },
                    {
                        "drugbank-id": "DB00414",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Acetohexamide"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Tenoxicam"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Piroxicam"
                    },
                    {
                        "drugbank-id": "DB00672",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Chlorpropamide"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Flurbiprofen"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Etodolac"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Mefenamic acid"
                    },
                    {
                        "drugbank-id": "DB00839",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Tolazamide"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "The metabolism of Salicylic acid can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01120",
                        "description": "The metabolism of Gliclazide can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01124",
                        "description": "The metabolism of Tolbutamide can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01131",
                        "description": "The metabolism of Proguanil can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The metabolism of Idarubicin can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01251",
                        "description": "The metabolism of Gliquidone can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "The metabolism of Lumiracoxib can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01289",
                        "description": "The metabolism of Glisoxepide can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB04557",
                        "description": "The metabolism of Arachidonic Acid can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB04725",
                        "description": "The metabolism of Licofelone can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB04898",
                        "description": "The metabolism of Ximelagatran can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06209",
                        "description": "The metabolism of Prasugrel can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "The metabolism of Lornoxicam can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "The metabolism of Zaltoprofen can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06803",
                        "description": "The metabolism of Niclosamide can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB08962",
                        "description": "The metabolism of Glibornuride can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11560",
                        "description": "The metabolism of Lesinurad can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13406",
                        "description": "The metabolism of Carbutamide can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13675",
                        "description": "The metabolism of Metahexamide can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01067",
                        "description": "The metabolism of Glipizide can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "The metabolism of Dexibuprofen can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Ketorolac"
                    },
                    {
                        "drugbank-id": "DB00304",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Desogestrel"
                    },
                    {
                        "drugbank-id": "DB00307",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Bexarotene"
                    },
                    {
                        "drugbank-id": "DB00471",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Montelukast"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Meloxicam"
                    },
                    {
                        "drugbank-id": "DB01029",
                        "description": "The metabolism of Irbesartan can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01357",
                        "description": "The metabolism of Mestranol can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB04938",
                        "description": "The metabolism of Ospemifene can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06739",
                        "description": "The metabolism of Seratrodast can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "The metabolism of Tranilast can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB12474",
                        "description": "The metabolism of Lynestrenol can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13941",
                        "description": "The metabolism of Piperaquine can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The metabolism of S Warfarin can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB14975",
                        "description": "The metabolism of Voxelotor can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "The metabolism of Parecoxib can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB15233",
                        "description": "The metabolism of Avapritinib can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Indomethacin"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Omeprazole"
                    },
                    {
                        "drugbank-id": "DB00440",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Trimethoprim"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Zidovudine"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Doxazosin"
                    },
                    {
                        "drugbank-id": "DB00624",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Testosterone"
                    },
                    {
                        "drugbank-id": "DB00701",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Amprenavir"
                    },
                    {
                        "drugbank-id": "DB00796",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Candesartan cilexetil"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "The metabolism of Acetylsalicylic acid can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "The metabolism of Ibuprofen can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06605",
                        "description": "The metabolism of Apixaban can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB08860",
                        "description": "The metabolism of Pitavastatin can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The metabolism of Netupitant can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13943",
                        "description": "The metabolism of Testosterone cypionate can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13944",
                        "description": "The metabolism of Testosterone enanthate can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "The metabolism of Testosterone undecanoate can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00957",
                        "description": "The metabolism of Norgestimate can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Capecitabine"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The metabolism of Dicoumarol can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The metabolism of Phenprocoumon can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The metabolism of Acenocoumarol can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The metabolism of Fluindione can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Dacomitinib"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Phenobarbital"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Phenytoin"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The metabolism of Warfarin can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The metabolism of Fosphenytoin can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB08875",
                        "description": "The metabolism of Cabozantinib can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Tamoxifen"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The metabolism of Erdafitinib can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB12371",
                        "description": "The metabolism of Siponimod can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of QTc prolongation and torsade de pointes can be increased when Sunitinib is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB05077",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06155",
                        "description": "The risk or severity of adverse effects can be increased when Rimonabant is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06624",
                        "description": "The risk or severity of adverse effects can be increased when Taranabant is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11903",
                        "description": "The risk or severity of adverse effects can be increased when GW842166 is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB12193",
                        "description": "The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB12649",
                        "description": "The risk or severity of adverse effects can be increased when Ibipinabant is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13070",
                        "description": "The risk or severity of adverse effects can be increased when Surinabant is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The risk or severity of adverse effects can be increased when WIN 55212 2 is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "The risk or severity of adverse effects can be increased when Nabiximols is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB14043",
                        "description": "The risk or severity of adverse effects can be increased when Palmidrol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB14737",
                        "description": "The risk or severity of adverse effects can be increased when Cannabinol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The risk or severity of serotonin syndrome can be increased when Phentermine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00704",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "The risk or severity of serotonin syndrome can be increased when Pseudoephedrine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Amantadine"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Lisdexamfetamine"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Mephentermine"
                    },
                    {
                        "drugbank-id": "DB01459",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Bezitramide"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with 2 5 Dimethoxy 4 ethylamphetamine"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Chlorphentermine"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Dextroamphetamine"
                    },
                    {
                        "drugbank-id": "DB08167",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Methylthioninium"
                    },
                    {
                        "drugbank-id": "DB09272",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Eluxadoline"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Iofetamine I 123"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Ritobegron"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Mephedrone"
                    },
                    {
                        "drugbank-id": "DB13454",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Nicomorphine"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Methoxyphenamine"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Gepefrine"
                    },
                    {
                        "drugbank-id": "DB13910",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Valproate bismuth"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "The risk or severity of serotonin syndrome can be increased when Buspirone is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The therapeutic efficacy of Ondansetron can be decreased when used in combination with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB00005",
                        "description": "The metabolism of Ondansetron can be increased when combined with Etanercept"
                    },
                    {
                        "drugbank-id": "DB00026",
                        "description": "The metabolism of Ondansetron can be increased when combined with Anakinra"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "The metabolism of Ondansetron can be increased when combined with Adalimumab"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The metabolism of Ondansetron can be increased when combined with Infliximab"
                    },
                    {
                        "drugbank-id": "DB01281",
                        "description": "The metabolism of Ondansetron can be increased when combined with Abatacept"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "The metabolism of Ondansetron can be increased when combined with Afelimomab"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "The metabolism of Ondansetron can be increased when combined with Apremilast"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "The metabolism of Ondansetron can be increased when combined with Canakinumab"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "The metabolism of Ondansetron can be increased when combined with Tocilizumab"
                    },
                    {
                        "drugbank-id": "DB06372",
                        "description": "The metabolism of Ondansetron can be increased when combined with Rilonacept"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "The metabolism of Ondansetron can be increased when combined with Golimumab"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The metabolism of Ondansetron can be increased when combined with Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "The metabolism of Ondansetron can be increased when combined with Secukinumab"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The metabolism of Ondansetron can be increased when combined with Siltuximab"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "The metabolism of Ondansetron can be increased when combined with Emapalumab"
                    },
                    {
                        "drugbank-id": "DB00268",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Ropinirole"
                    },
                    {
                        "drugbank-id": "DB11823",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Esketamine"
                    },
                    {
                        "drugbank-id": "DB00395",
                        "description": "The risk or severity of adverse effects can be increased when Carisoprodol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB06711",
                        "description": "The risk or severity of CNS depression can be increased when Naphazoline is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB12015",
                        "description": "The serum concentration of Ondansetron can be decreased when it is combined with Alpelisib"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "The risk or severity of CNS depression can be increased when Ondansetron is combined with Eszopiclone"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The risk or severity of sedation can be increased when Clonidine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Lefamulin may increase the QTc prolonging activities of Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00924",
                        "description": "The risk or severity of CNS depression can be increased when Ondansetron is combined with Cyclobenzaprine"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of sedation can be increased when Metoclopramide is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The metabolism of Dronedarone can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Lasmiditan"
                    },
                    {
                        "drugbank-id": "DB15066",
                        "description": "The serum concentration of Ondansetron can be increased when it is combined with Givosiran"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Ondansetron can be decreased when it is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The serum concentration of Ondansetron can be increased when it is combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The risk or severity of serotonin syndrome can be increased when Tramadol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Ondansetron can be increased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "The metabolism of Tucatinib can be decreased when combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The serum concentration of Ondansetron can be increased when it is combined with Fluoxetine"
                    },
                    {
                        "drugbank-id": "DB00574",
                        "description": "The risk or severity of serotonin syndrome can be increased when Fenfluramine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB12404",
                        "description": "The risk or severity of sedation can be increased when Ondansetron is combined with Remimazolam"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Ondansetron can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The risk or severity of hypotension sedation death somnolence and respiratory depression can be increased when Ondansetron is combined with Oliceridine"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Ondansetron can be decreased when it is combined with Satralizumab"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}